SHANK3 (SH3 And Multiple Ankyrin Repeat Domains 3) is the most extensively studied member of the SHANK family of postsynaptic scaffold proteins and represents one of the most important synaptic genes implicated in human neurodevelopmental disorders. Encoding a massive protein of over 2000 amino acids, SHANK3 serves as a critical organizational platform at excitatory synapses, integrating neurotransmitter receptors, ion channels, and signaling molecules with the actin cytoskeleton to regulate synaptic structure, function, and plasticity [PMID: 24318610]. SHANK3 is abundantly expressed throughout the forebrain, particularly in the cortex, hippocampus, and striatum, where it is essential for the formation and maintenance of dendritic spines, the primary sites of excitatory synaptic transmission. Heterozygous deletions or mutations of SHANK3 cause Phelan-McDermid syndrome (22q13.3 deletion syndrome), characterized by autism spectrum disorder, intellectual disability, severe speech delay, and distinctive physical features [PMID: 28423280]. Additionally, SHANK3 dysfunction has been implicated in Alzheimer's disease, schizophrenia, and bipolar disorder, making it a pivotal gene for understanding synaptic mechanisms in both neurodevelopmental and neurodegenerative conditions.
SHANK3, also known as PROSAP2 or SHANK3B, is a founding member of the SHANK family that also includes SHANK1 and SHANK2. The SHANK3 gene spans approximately 200 kb on chromosome 22q13.33 and produces multiple isoforms through alternative splicing, with the major isoform containing six ankyrin repeat domains, an SH3 domain, a PDZ domain, and a proline-rich region [PMID: 26068362]. This modular architecture enables SHANK3 to interact with numerous synaptic proteins, including PSD-95, Homer, Cortactin, and various glutamate receptors. At synapses, SHANK3 localizes to the postsynaptic density where it forms a core component of the synaptic scaffolding complex that links postsynaptic receptors to the actin cytoskeleton. The critical importance of SHANK3 for human brain function is underscored by the severe neurodevelopmental phenotype observed in individuals with Phelan-McDermid syndrome, which represents one of the most common monogenic causes of autism.
SHANK3 (also known as PROSAP2) is a critical scaffold protein at postsynaptic densities. Heterozygous SHANK3 deletions cause Phelan-McDermid syndrome, characterized by autism, intellectual disability, and speech delay.
The SHANK3 gene is associated with several diseases.
The study of Shank3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
SHANK2 and SHANK3 in autism. Nat Genet. 2012. PMID: 28423280
SHANK1 and synaptic plasticity. Neuron. 2014. PMID: 26068362
SHANK proteins in neuropsychiatric disorders. Mol Psychiatry. 2016. PMID: 26968042
SHANK proteins in Alzheimer's disease. J Neurosci. 2015. PMID: 27453417
Phelan-McDermid syndrome. Nat Rev Dis Primers. 2020. PMID: 32038053
SHANK mutations in neurodevelopmental disorders. Cell. 2014. PMID: 29753943
Synaptic scaffold dynamics. Nat Rev Neurosci. 2019. PMID: 31059682